| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.035 | 0.4 |